( | ) | ( | ) |
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED |
No. JPCS-22/011
19 July 2022 | |
RE: | Report on use of proceed from IPO ended 30 June 2022 |
TO: | Director and Manager, The Stock Exchange of Thailand |
On 21, 25 and 26 October 2021, JSP Pharmaceutical Manufacturing (Thailand) PCL. ("the Company") issued 115,000,000 newly ordinary shares by Initial Public Offering ("IPO") with issue price at THB 7.00 per share. Later, the Company registered ordinary shares to the Market of Alternative Investment ("mai") on 2 November 2021. In this regard, the Company received proceed from IPO totalled THB 805.00 million. After deducting underwriting fees and other related costs of this issuance, the Company had net proceed amounting to THB 755.38 million.
The Company would like to report the use of IPO proceed ended 30 June 2022 as follow:
Remaining | |||||||
proceed as of | Actual use of | Remaining | |||||
Estimated use | 31 December | proceed ended | proceed as of | ||||
Use of proceed objectives | of proceed | 2021 | 30 June 2022 | 30 June 2022 | |||
(Unit : THB million) | |||||||
1. | New product development | 20.00 | 20.00 | 8.52 | 11.48 | ||
2. | Develop, present and PR | 200.00 | 180.18 | 14.02 | 166.16 | ||
advertisements | |||||||
3. | Renovate and expand factories | 294.35 | 67.47 | 226.88 | |||
298.00 | |||||||
4. | Repayment of loans from | 100.00 | 11.92 | 11.92 | - | ||
financial institutions | |||||||
5. | Working capital for operations | 137.38 | 107.71 | 38.62 | 69.09 | ||
Total | 755.38 | 614.16 | 140.55 | 473.61 | |||
Please be informed accordingly
( | ) | ( | ) |
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED |
Sincerely yours,
JSP Pharmaceutical Manufacturing (Thailand) PCL.
(Mr. Kriangkrai Rungruangthaweekul)
Vice President of Finance
Investor Relations
Tel 064 479 1691
Emailir@jsppharma.com